Abdel Rahim A. Hamad

2.5k total citations
51 papers, 2.0k citations indexed

About

Abdel Rahim A. Hamad is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Abdel Rahim A. Hamad has authored 51 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 11 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in Abdel Rahim A. Hamad's work include T-cell and B-cell Immunology (24 papers), Immune Cell Function and Interaction (19 papers) and Diabetes and associated disorders (10 papers). Abdel Rahim A. Hamad is often cited by papers focused on T-cell and B-cell Immunology (24 papers), Immune Cell Function and Interaction (19 papers) and Diabetes and associated disorders (10 papers). Abdel Rahim A. Hamad collaborates with scholars based in United States, Japan and China. Abdel Rahim A. Hamad's co-authors include Sanjeev Noel, Ankit Saxena, Shukti Chakravarti, Hamid Rabb, Thomas Donner, Seakwoo Lee, Philippa Marrack, Jonathan P. Schneck, John W. Kappler and Rizwan Ahmed and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Abdel Rahim A. Hamad

45 papers receiving 1.9k citations

Peers

Countries citing papers authored by Abdel Rahim A. Hamad

Since Specialization

Citations

This map shows the geographic impact of Abdel Rahim A. Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdel Rahim A. Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdel Rahim A. Hamad more than expected).

Fields of papers citing papers by Abdel Rahim A. Hamad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdel Rahim A. Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdel Rahim A. Hamad. The network helps show where Abdel Rahim A. Hamad may publish in the future.

Co-authorship network of co-authors of Abdel Rahim A. Hamad

This figure shows the co-authorship network connecting the top 25 collaborators of Abdel Rahim A. Hamad. A scholar is included among the top collaborators of Abdel Rahim A. Hamad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdel Rahim A. Hamad. Abdel Rahim A. Hamad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Renal Tubular Epithelial Cell-Derived IL-7 Drives Expansion and Protective Effects of Double-Negative T Cells in Acute Kidney Injury 2025 ·Immunological Investigations ·Mohanraj Sadasivam, Sanjeev Noel, Kyungho Lee, (unknown), Hamid Rabb, Abdel Rahim A. Hamad	1
2	The Lasting Impact of IL-2: Approaching 50 Years of Advancing Immune Tolerance, Cancer Immunotherapies, and Autoimmune Diseases 2025 ·Immunological Investigations ·(unknown), (unknown), (unknown), (unknown), (unknown), Sarju Ganatra, (unknown), (unknown), (unknown), Bardia Nourbakhsh, Abdel Rahim A. Hamad	0
3	577P A real-world analysis of immune checkpoint inhibitors outcomes in patients with baseline auto-immune diseases 2024 ·Annals of Oncology ·(unknown), Hazem Elewa, (unknown), (unknown), (unknown), (unknown), Ambrine Sahal, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Abdel Rahim A. Hamad	0
4	571P The economic sequelae of immune related adverse events secondary to immune checkpoints inhibitors in Qatar: A hospital-perspective analysis 2024 ·Annals of Oncology ·(unknown), (unknown), Hazem Elewa, (unknown), (unknown), (unknown), (unknown), Ambrine Sahal, (unknown), (unknown), (unknown), S. M. Nasser, (unknown), (unknown), (unknown), Abdel Rahim A. Hamad	1
5	Kidney Immune Cell Characterization of Humanized Mouse Models 2023 ·Kidney360 ·Sanjeev Noel, Johanna T. Kurzhagen, Sul A Lee, Mohanraj Sadasivam, Abdel Rahim A. Hamad, Phillip M. Pierorazio, Hamid Rabb	1
6	Renal tubular epithelial cells are constitutive non-cognate stimulators of resident T cells 2023 ·Cell Reports ·Mohanraj Sadasivam, Chunfa Jie, Abdel Rahim A. Hamad	5
7	Detection, sorting, and immortalization of dual expresser lymphocytes from human peripheral blood samples 2021 ·STAR Protocols ·Rizwan Ahmed, (unknown), Zahra Omidian, (unknown), (unknown), Abdel Rahim A. Hamad	0
8	Unexpected alliance between syndecan-1 and innate-like T cells to protect host from autoimmune effects of interleukin-17 2018 ·World Journal of Diabetes ·Anil K. Jaiswal, Mohanraj Sadasivam, Abdel Rahim A. Hamad	9
9	Expansion of FasL-Expressing CD5+ B Cells in Type 1 Diabetes Patients 2017 ·Frontiers in Immunology ·Ankit Saxena, Hideo Yagita∥, Thomas Donner, Abdel Rahim A. Hamad	14
10	Double-Negative αβ T Cells Are Early Responders to AKI and Are Found in Human Kidney 2015 ·Journal of the American Society of Nephrology ·(unknown), Sanjeev Noel, Ankit Saxena, (unknown), (unknown), Chunfa Jie, Lois J. Arend, Mohamad E. Allaf, Hamid Rabb, Abdel Rahim A. Hamad	64
11	Double Negative (DN) αβ T Cells: misperception and overdue recognition 2014 ·Immunology and Cell Biology ·(unknown), Sanjeev Noel, Ankit Saxena, Hamid Rabb, Abdel Rahim A. Hamad	59
12	Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy 2014 ·Cytokine ·Ankit Saxena, (unknown), Sanjeev Noel, (unknown), Thomas Donner, Abdel Rahim A. Hamad	242
13	The potential of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes 2012 ·Frontiers in Immunology ·Abdel Rahim A. Hamad, Kristin M. Arcara, (unknown), Thomas Donner	16
14	Inhibition of Fas Ligand in NOD Mice Unmasks a Protective Role for IL-10 against Insulitis Development 2011 ·American Journal Of Pathology ·Zuoxiang Xiao, (unknown), (unknown), (unknown), (unknown), Andrew Marshall, Hiroaki Kimura, Patrizio Caturegli, Karl L. Womer, Yanfei Huang, Chunfa Jie, Shukti Chakravarti, Jonathan P. Schneck, Hideo Yagita∥, Abdel Rahim A. Hamad	24
15	Blocking Fas Ligand on Leukocytes Attenuates Kidney Ischemia-Reperfusion Injury 2011 ·Journal of the American Society of Nephrology ·Gang Jee Ko, Hye Ryoun Jang, Yanfei Huang, Karl L. Womer, Manchang Liu, Elizabeth Higbee‐Dempsey, Zuoxiang Xiao, Hideo Yagita∥, Lorraine C. Racusen, Abdel Rahim A. Hamad, Hamid Rabb	39
16	Extracellular Matrix Lumican Deposited on the Surface of Neutrophils Promotes Migration by Binding to β2 Integrin 2009 ·Journal of Biological Chemistry ·Seakwoo Lee, (unknown), Abdel Rahim A. Hamad, Shukti Chakravarti	68
17	Protection from Autoimmune Diabetes and T-Cell Lymphoproliferation Induced by FasL Mutation Are Differentially Regulated and Can Be Uncoupled Pharmacologically 2007 ·American Journal Of Pathology ·(unknown), Mehmet Güler, Zuoxiang Xiao, Dongfeng Zheng, Allan D. Hess, Yi Wang, Hideo Yagita∥, Jonathan P. Schneck, Abdel Rahim A. Hamad	22
18	B220+ Double-Negative T Cells Suppress Polyclonal T Cell Activation by a Fas-Independent Mechanism That Involves Inhibition of IL-2 Production 2003 ·The Journal of Immunology ·Abdel Rahim A. Hamad, (unknown), (unknown), Ching-Tai Huang, (unknown), Jonathan P. Schneck	40
19	Lack of Coreceptor Allows Survival of Chronically Stimulated Double-Negative α/β T Cells 2001 ·The Journal of Experimental Medicine ·Abdel Rahim A. Hamad, (unknown), Paria Mirmonsef, Chris P. M. Broeren, Carl H. June, Drew M. Pardoll, Jonathan P. Schneck	20
20	Murine Transfer Factors: Dose-Response Relationships and Routes of Administration 1995 ·Cellular Immunology ·Charles H. Kirkpatrick, Abdel Rahim A. Hamad, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact